Hogan Lovells counsels Bioretec in first ever De Novo grant for bioresorbable metal trauma screw. Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, in securing Food...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised P-Cure in the authorization process. P-Cure, an Israeli med-tech company, in U.S. Food and Drug Administration (FDA) market clearance for a proton therapy...
You must be a Standard 1 Year member to access this content.
Hogan Lovells counseled Lucira Health, Inc. Lucira Health, Inc. (Lucira), a medical technology company focused on the development of innovative infectious disease tests, secured U.S. Food...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised Apollo Endosurgery, Inc. on the deal. Apollo Endosurgery, Inc., a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, in...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised NONAGON on the deal. NONAGON (previously named MyHomeDoc) through the U.S. Food and Drug Administration 510(k) clearance process for its N9 multisensory device...
You must be a Standard 1 Year member to access this content.
